Personalized Lipid Management in Maryland
Endothelial Function and Dysfunction: The Vascular Balancing Act
The endothelium lines your blood vessels and keeps them healthy. When it becomes dysfunctional, inflammation, stiffness, and plaque can silently develop. This article explains how endothelial dysfunction contributes to heart disease and metabolic conditions, and how personalized strategies can reverse it through lifestyle changes, advanced testing, and targeted therapies.
Published
How the ASCVD Risk Calculator Guides Smart Prevention
The ASCVD Risk Calculator estimates 10-year heart and stroke risk using basic lab and clinical data. But numbers alone don’t tell the full story. Learn how thoughtful care, deeper lipid testing, and an individualized strategy can guide smarter prevention—especially for those with silent risks or early metabolic changes.
Published
When Hypertension and Dyslipidemia Collide: A Double Risk for the Heart
Hypertension and dyslipidemia often appear together. They silently damage blood vessels and raise cardiovascular risk. Their shared root in metabolic dysfunction requires thoughtful, personalized care. Addressing both conditions with smart strategy helps prevent stroke, heart attack, and kidney disease—especially with a holistic approach offered here in Montgomery County, Maryland.
Published
Why Non-HDL Cholesterol Still Matters
Non-HDL cholesterol includes all dangerous cholesterol types, not just LDL. This makes it a stronger tool for predicting cardiovascular risk—especially in patients with diabetes, obesity, or high triglycerides. It plays a key role in individualized, comprehensive lipid care focused on preventing heart disease before it starts.
Published
Statins vs. Natural Products for Lowering Cholesterol
Cholesterol is mostly made by the liver—not food. Statins target this process directly and remain key for high-risk patients. Natural products offer some benefit but work differently. This blog compares both options clearly and highlights the value of thoughtful, individualized care in cholesterol management.
Published
Lower LDL Cholesterol May Protect the Brain from Dementia
A New Look at LDL and Cognitive Health We often hear about bad cholesterol—low-density lipoprotein cholesterol (LDL-C)—as a major cause of heart disease. But what about its role in brain health? A new study from a large university hospital network in South Korea helps clarify the link between LDL-C levels and dementia risk. The results are both surprising and reassuring. The Study at a Glance Researchers analyzed data from 11 university hospitals using a shared…
Published
A New Way to Lower Lipoprotein(a): What Patients Should Know
Lipoprotein(a), or Lp(a), is a cholesterol-like particle made in the liver. Unlike LDL or “bad” cholesterol, Lp(a) levels are mostly inherited. You can have high levels even with a healthy lifestyle. Researchers have now tested a new treatment called lepodisiran, an investigational small interfering RNA therapy. It’s designed to block the liver from making Lp(a). The results are promising.
Published
The Importance of Lowering Saturated Fat Intake for Heart Health
Saturated fats raise LDL cholesterol and ApoB by impairing the liver’s ability to remove cholesterol the bloodstream. This occurs because saturated fats reduce LDL receptor activity, slowing cholesterol clearance. As LDL particles accumulate, they penetrate artery walls, triggering inflammation and plaque formation.
Published
A Brief History of Lipoprotein(a)
Lipoprotein(a), or Lp(a), is one of the most intriguing molecules in cardiovascular research. Though less known than LDL or HDL cholesterol, its role in heart disease is undeniable. Understanding its history reveals how science has gradually unraveled its significance and potential for treatment.
Published
Cholesterol Mysteries: How ApoB100 and LDL Receptors Bind
Understanding cholesterol metabolism at a molecular level is critical to improving heart health. Recent research offers fresh insights into the relationship between apolipoprotein B100 (apoB100) and low-density lipoprotein (LDL) receptors (LDLR). These findings not only clarify the mechanics of cholesterol metabolism but also open exciting possibilities for future treatments.
Published